Professor Guy Pratt is a Consultant Haematologist at University Hospitals Birmingham NHS Foundation Trust and a Professor of Haematology (Haemato-Oncology) at the University of Birmingham. He also serves as the Deputy Director of the Cancer Research UK Clinical Trials Unit, where he oversees haematology trials.
Education and Training
Professor Pratt trained at Cambridge University, qualifying in 1989. Following his junior doctor training in London, he specialized as a registrar in Haematology in Liverpool and Leeds, completing an MD thesis on multiple myeloma in Leeds.
Clinical Practice and Specialisation
Since 2001, Professor Pratt has been a Consultant Haematologist in Birmingham. His main clinical and research interests include multiple myeloma, chronic lymphocytic leukaemia (CLL), Waldenström’s macroglobulinaemia, and related plasma cell disorders. At University Hospitals Birmingham, he plays a crucial role in treating these conditions and developing targeted treatment strategies.
Research and Contributions
Professor Pratt has a strong research background, particularly in the tumour microenvironment in multiple myeloma and the use of mass spectrometry to measure myeloma proteins. He has been involved in numerous clinical trials both locally and nationally and has a prolific publication record, with over 380 papers and systematic reviews. He was the clinical lead for the 2016 NICE myeloma guidelines and has held several national roles, including BSH guideline lead for Haemato-Oncology and chair of the BSH science and publication committee.
Membership and Recognition
He is a member of various professional organizations, including the British Society for Haematology (BSH), UK Myeloma Society, and International Myeloma Working Group. He is also a trustee of Cure Leukaemia and has been actively involved in patient advocacy and educational initiatives for healthcare professionals.
Collaborative Initiatives and Services
Professor Pratt’s work includes examining the metabolic changes in multiple myeloma and its precursor states, developing novel therapies, and enhancing clinical trial frameworks to advance haematological research and patient care.
University Hospitals Birmingham
- Works for: University Hospitals Birmingham NHS Foundation Trust, University of Birmingham
- Member of Organisations:
- British Society for Haematology (BSH)
- UK Myeloma Society
- Cure Leukaemia (Trustee)
- UK Myeloma Research Alliance
- International Myeloma Working Group
- Occupation: Consultant Haematologist, Professor of Haematology (Haemato-Oncology), Deputy Director of the Cancer Research UK Clinical Trials Unit
- Alumni Of: University of Cambridge
- Qualifications: MA, MBBChir, MD, FRCP, FRCPath
- Main Contact URL:
